Abstract  by unknown
1 ABSTRACTS- Poster
Pra PTCA TIMI HOW Pre PTCA CTFC Post PTCA CTFC Delta CTFC
TIMI 0/1 Occluded 28.5 + 16.5, n = 70 Nonapplicable
TIMI 2 63.2 + 37.0, n = 25 26.3+ 17.8, n = 19 43.7+42.6, n = 19
TtMl 3 30.6 + 9.9, n = 19” 20.5+ 11.5, n =16 10.3* 12.8, n = 16
TtMl 2 or3 49.1 & 32.6, n = 44 23.5& 15.1, n =37 27.4 k 35.6, n =37
Previously we reported that normalarteriesin the absence of acute Ml
have a CTFC of 21.0 + 3.1 (n = 78). PTCA of arteries with TIMI 3 Flow
reatored a normal CTFC (20.5 vs 21.0, p = NS). Adjunctive PTCA of arteries
with TIMI 2 flow improved flow by 43.7 frames (p = 0.0006) but did not restore
a normal CTFC (26.3 vs 21.0 p = 0.01) and approximates that repotted for
non-culprit arteries in acute Ml (25.5 frames). Likewise, rescue PTCAof TIMI
0/1 flow did not restore a normal CTFC (28.5 vs 21.0, p = 0.0001). Slower
Pra PTCA CTFCS were correlated with greeter improvements in CTFC (r =
0.91, p -=0.0001). Conclusions: PTCAof the residual stenosis in arteries with
TIMI 3 flow atter thromboiysis results in normal flow (CTFC = 21). Although
PTCA of the reeidual stenosis in arteries with TIMI 2 flow greatly improves
flow, the flow remains peraietently slowed by 5 frames (20% > normal). This
5 frame delay is similar to that observed in non-culprit arteries in acute Ml,
& may reflect a peraietent abnormality in microvascular reeistence.Whether
PTCA of atteries with TIMI 2 flow improves clinical outcomea remains to be
determined. -
m94620 Clinical Usefulness of Dual SPECT Imaging ofTc.ggm ~stamibi and 1231-IPPA for Predicting
Myocardial Viability After Thrombolyaed
Myocardial Infarction
M. Pence, S. Romano, S. Rosanio, M. Tocchi, A. Vitarelli, A. Dagianti,
M. Benci, F. Scopinero 1,F. Fedele, A. Dagianti. Dpt. of Cardiovascular and
Respiretory Sciences, “Le Sepienza” University Rome, /ta@,1Dpt. of
Experimental Medicine, “La Sapienza” Unive~ity Rome, Itafy
There ie controversy on the value of Tc-99m Sestamibi SPECT (MIBI) for
detection of myocerdial viability. This study”wae performed to investigate
the ability of MIBI in conjunction with 1231-Phenylpentadaoenoicacid (IPPA)
in identifying dysfunctional but viable myocardium after earty (<4 hours)
thromlmlytic treatment for myocerdial infarction (Ml). We compared, in mr-
responding myocerdial segments, perfusion and metabolic patterns in 22
petienta with firat uncomplicated Ml (16 males, age 36t064 yra) after4 * 1.5
daya from symptoms oneet. Myocardial viability wea defined by the discrep-
ancy bStWSenparfueion defect on MIBI and fatty acid metabolism on IPPA
SPECT:dual SPECTimage aequieition in 3 projactione (anterior,45Qand 71Y
tAO) wea carried out at 60 min from MIBI and 30 min from IPPA injections.
The Ieftventricle weadivided into 9 eagmente (apex, 4distel and4besal seg-
mente) and analyzed using a quantitative uptake score as normal = 1, mild
reduction =2, eevere reduction= 3, defect =4. Toassessfunctional recovery
of eaynergic areas, all patients underwent 2D achocardiography evaluating
wall motion score index (WMSI) and ejeetion fraction (EF) on the same day
of radionuclide imaging and 8 weeke after: improvement was defined as
decrease of WMSI ? 1. WMSI at baeeline well correlated with IPPA score (r
= o.i’6, p < 0.01) while did not with MIBI score (r= o.61, P = ne). The lppA
score wae significantly larger than the MIBI score (6.7 +3.1 vs 3.4+2.1, p <
0.01) The discrepancy between IPPA and MIBI was significantly correlated
with the extent of the improvement of WMSI (r= 0.66, p < 0.01) and of EF (r =
0.60, p c 0.01) at 6 weeks. In conclusion, the identification by dual MIBI and
IPPA SPECT of segmental metabolism-perfusion mismatch (possibly due
to stunning phenomenon after thrombolysad myooerdial infarction) predicts
myoeardial viability and later recovery.of left ventricular contractile function.
D94621 Pereietent Myoglobin Elevetion ia Associated withSlower Flow in Patent Culprit Afteries Following
Successful Thrombolysis
M. Rizzo, 1.Doteni, C. McLean, K. Ryan, C. McCabe, M. Tanasijevic,
C. Cannon, M. Gibson, E. Braunwald, for the TIMI IOA Trialists. Wast
Roxbwy VAMedical Center and Brfgham & Women’s Hospital, Boston, MA,
USA
This study examined the relationship between the release of myoglobin and
blood flow in patent culprit atieries at 90min. following thrombolyais with TNK
in TIMI loA. The frames required for dye to reach standard landmarks were
counted to arrive at the Corrected TIMI Frame Count (CTFC), a previously
described index of coronary blood flow. Slower 90 min. flow (i.e. higher
CTFCS)was correlated with higher12 hour(r= 0.66, p = 0.13331,n = 34), &
higher24 hourmyoglobinlevels(r= 0.65, p = 0.0001, n = 35) (24 hourdata
showninfigure)andtendedto behigherat 6 houra(r= 0.32, p =0.056). The
24 hr. mean myoglobin of pta. with slow flow (CTFC z 40) (116.5 + 65.5, n
=9) did not differ from that of pts. with a closed artety (137.8 & 156.9, n = 5,
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P= NS)butwashigherthanpta.withmore rapid90 min.flow (CTFC c 40)
(55.5 + 4.7, n = 26, p = 0.001).
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Conclusions: Slower flow in patent culprit arteries at 90 min. folIowing
thrombolysis is associated with a persistent elevation of myoglobin at 12 and
24 hra which approximates that observed in occluded arteriee, possibly as a
result of delayed washout.
1946-22]D*aTIMIFramecountRefledMYo.ardialBled
Flow?
A. Huizenga, W.R.M. Aengevaeren, T. van der Werf, F.W.A.Verheugt.
Depetiment of Cardiology, University Hospital Nijmegen, The Netherlands
TIMI frame count (TFC), presented as a simple, reproducible quantitative
index of coronary blood flow, is the numbarof frames needed for the appear-
ance of the front of the contrast bolus !O reach predefine distal landmarks.
From the indicetordilution thaory follows, however, that appearance time has
only a weak relation with flow. Mean transit time (MTT), on the other hand,
ie fundamentally related to myooardial flow. The MTT-method has been suc-
cessfully teeted against direct flow measurements in dogs. Therefore, we
coneiderad a comparison between the simply applicable TFC and laborious
MTT ueeful.
We atudisd 109 coronary arteriograms of atable patienta, previously in-
cluded into cholesterol lowering trials, from whom the MU’S were alrasdy
aseessed. TFC was determined by 2 independent angiogrephera, blinded
to the MTT date. If this reaulted in a difference of >5 framee, oonsensue
was reached with a third obaewer. MU, from injection site to a myocar-
dial area of interest, was assessed by digital subtraction angiography with
videodensitometric analyses of the time couffie of the contrast.
Linear regression analysis between TFC (frames) and MU (see) on all
arterial and on LAD, LCX and RCA territories separately showed correlation
coefficients of 0.12, 0.20, 0.26 and 0.31, respectively. These poor reeultadid
not change substantially by excluding thoee observations, in which there was
a difference of >5 frames between observera (about 20% of all oases).
Conclusion: Ae expected, TFC does not seem to reflect myocerdial flow,
as measured by MU, instable coronary patients. TFC, therefore, is probably
of limited value in the quantitation of myocerdial blood flow restoration in
acute myocardial infarction.
1946-231Translumina,EfiraCtiOnAthereCtomy.va.Balloon
angioplasty in Acute Ischemic Syndromes (TOPIT):
Hospital outcome and six-month status
T.L. Schreiber, B.M. Kaplan, M.L. Gregory, C.L. Brown, Ill, D.G. Rizik,
R.R. Masden, A. Brahimi, W.W. O’Neill. William Beaumont Hospital, Royal
Oak, Ml, USA, St. John Hospital, Detroit, Ml, USA
The TOPIT Trial is a randomized, multicanter study comparing the use
of tmnsluminal extraction atherectomy (TEC) veraus balloon angioplaaly
(PTCA) in native veesels for clinical situation which are associated with in-
traooronaty thrombue. We hypothesize that pretreatment with TECenhances
outcome during percutaneous revascularization for high rick patiente with
acute ischemic ayndromes. 115patients (mean age 60.Ojwere randomized
to TEC while 135 patients (mean age 56.7 year) to PTCA. Clinical indioe-
tiona included pnmaty reperfusion for acute myocardial infarction (31.6f%),
unatable angina (30.8%), post-infarction angina (24.8%), and thromboifiic
failure (10%),
Outcomes were:
TEC 115 PTCA 135 0 value
Death in hospital 1 (0.67”A) o NS
EmergentCABG 1 (0.s7%) 1 (0.s7%) NS
Emergent PTCA 5 (4,35%) 5 (3.70”/0) NS
Initial% stenosis 75.2 + 16.7 76.6 & 17.5 NS
Final ‘A stenoais 26.2 & 1S,4 27.6 + 16.9 NS
Final% thrombosis 6“/0 3% NS
3x increase CPK 1.6.3% 5.69% o.oa2
. r. .,..- . --- - --- .JACC February 1997
In conclusion, TEC atheractomy led to enhanced clinical safety in percu-
taneous revascularization during acute ischemicstates, while augmenting-6-
month outcome. Ita routine use during acute ischemic syndrome revaecular-
izatlon may now be considered for the technloally suitable vessel. Six month
follow up to be presented.
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FrequentAfterPrimeryPTCAforAcute
MyocardlalInfarction
D. Czitrom, E. Brochet, D. Karila-Cohen, P.Seknadji, J.-M. Juliard,
P.G.Steg, P.Assayag. Service de Cardiologie, Hopital Bichat, Paris, France
No-reflow, defined as incomplete recovery of myocardial perfusion after re-
establishment of patency of the infarct-related artery during acute myooardial
infarction (Ml), has been linked to worse prognosis, including heart failure
and left ventricular remodeling.
We prospectively studied no reflow by myocardial contrast echocerdio-
grephy (MCE) in 14 Pts with acute Ml (10 anterior and 4 inferior), treated by
primary PTCAwithin 6 hours (average time to TIMI 3 patency: 212 * 12 rein)
of Ml onset. MCE was performed by injection of sonicated ioxaglate in both
Infarc+ and non-infarct-related aiteries during corona~ angiography acutely.
Coronary angiography and simultaneous MCE were repeated 9 + 1 days
later. Myocerdial perfusion was graded semi-quantitatively by 2 independent
observers using a score of O, 0.5 and 1 for each ASE echocardiographic
segment from the myocardial area at risk (defined as hype- or akinetic seg-
ments; n = 95 segments). Echographic wall motion was graded on a score
from 1 (normokinesia) to 3 (akinesia).
After PTCA-induced TIMI 3 patency, MCE score was Oin 20%, 0.5 in 27%
and 1 In 53% of segments, respectively. At restudy, this score was Oin 10%,
0.5 in 14% and 1 in 76% of segments, respectively. Therefore, perfusion
was abnormal in 47% of segments acutely and in only 24% at predischarge
(p = 0.006). The average perfusion score per segment was O.W + 0.04
acutely and increased to 0.82 + 0.03 at restudy (p= 0.001). This increase in
“perfusion score was associated with a decrease in the average wall motion
grade: 2.8 * 0.04 acutely and 2.5+ 0.08 at day 9 (p < 0.01).
This important recovev of MCE-assessad myocardial perfusion within
daya (despite substantial acute no-reflow) suggests that primaty PTCA-
induced reperfusion results in effective protection of the myccardial mi-
crovasculature and may explain the early functional recovery,assessed by
echocardiography.
Pharmacologic Strategies to Reduce the
Extent of Myocardial Infarction
Monday,March 17, 1997, 3:00 p.m.
AnaheimConventionCenter, E
p.m.
i
M. Marzilli, E. Gliozheni, S. Fedele, L Ungi, E. Oreini, P.Marreccini. CNR,
hstitute of C/irrica/Pfrysio/ogy, Pisa, Italy
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consecutive patients with AMI for direct
PTCA between 1991 and 1995. Twenty (Group 1) received intracoronary
adenoeine (4 mg over 4 minutea) and 20 intracoronaty saline (Group ii).
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+ O I 2.7 + 0.6 in group 11,p = 0.043), in
the incidence of Q wave Ml (50% in group i vs 80% in group H,p = 0.0467)
end of clinically assesed LV failure (O% in groupI vs 20% in group H,p =
0.035). Peak CPK value was higher in saline patients (1994 + 1782 UI in
group I va 2803 + 1857 UI in group H,p = NS).
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K, Kodama, Y.-J. Lim 1, F. Ishikura, A. Hirayama. Osaka Po//ce
Hospital, Osaka, Japan, 1Kawachi General Hospital, Higashi-Osaka, Japan
Salutary effect of nlcorandll, a K+-ATP channel opener, on restoration of
myocardial blood flow and functional improvement after ooronary revascular-
ization was investigated. Twenty patients with first anterior acute myocardial
infarction (AMI) who underwent coronary recanalization within 6 hours of the
onset were divided Into 2 groups: 10’patients who raoeived an adjunotive
intracomnary dose of 2 mg of nicorandil just after successful coronary reflow
(group A) and the other 10 patients who obtained successful coronary reflow
only (group B). Myocardial contrast echocardiography (MCE) was performed
beforeand15 minutes affercoronary reflow and 5minutesafterthe nicorandil
administration. MCE imageswere analyzed to determine peak contrast inten-
sity in the infarct and non-infarct areas, and their ratio (Pl ratio) was used to
assess microvascular integrity in the infarcl area. Regional wall motion in the
infarct area was serially assessed by two-dimensional echocardiography just
after coronary reflow and a month later (scores of O,normal, to 4, dyskinetic).
Thare was no difference in the wall motion score or the PI ratio juat after
coronary reflow between groups A (30 segments) and B (31 segments). ln-
tracoronary administration of nicorandil in group A improved the PI ratio from
0.27 + 0.25to 0.53 + 0.42 (p < 0.001), and provided greater improvement in
the wall motion score in a month compared to group B (2.8+ 0.7to 1.7 + 0.9
vs 2.7 & 0.5 to 2.4 + 0.8; p < 0.01). Thus we concluded that Intraooronaty
nicorandil administration restored blood flow within the infarct myocardium
and provided greater functional improvement in a month, suggestingthe
usefulnessof nicorandiladministrationas an adjunctivetreatmentfollowing
coronaryreflowinAMI patients,
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J.A. Rodriguez,1,Godoy,P.Castro,J.C. Quintana,E. Chavez, R. Corbelan.
Dept. of Cardiovascular Diseases, Catholic University of Chile, Santiago,
Chile
Leftventriculardilatationandprogreaaivesystolicdysfunctionfollowingacute
myocerdialinfarction(AMI) havebeen preventedby ACE inhibition.The rel-
ative importanceof aldosteronein this reaponse is uncertain. In a placebo
controlled, double blinded, randomized trial, we compared remipril (R) and
spironolactone (S), an aldostarone receptor antegoniet, in patients with im-
paired ejection fraction (EF) post AMI. Geometric left ventricular remodeling
was assessed baseline (B) and foliowing 6 months (m) of treatment. Patients
were randomly assigned to placebo (P, n = 18), R (2.5 mg b.i.d., n = 22)
or S (25 mg t.i.d., n = 15) on day 5 poet Ml. Groups were simiiar in age,
gender, AMI location, Killip class, incidence of thromboiysis (mean = 41%),
angioplasty (mean = 8%), surgical revascularization (mean = 5%) or addi-
tional medication: aspirin (mean = 90%), nitrates (mean = 31%), B-blockers
(mean = 28%), diuretics (mean = 18%) and digitalis (mean = 9%). Ejec-
tion fraction (EF), left ventricular end diastolic (EDVJand end systolic (ESV)
volumes were obtained by mitigated radionuclide angiography. Values are
expressed as mean + standard error.
EF(“A) EOV(ml) ESV(ml)
B 6m B 6m B 6m
P 39* 3 33* 3 127& S 166i 12 75& 6 109l 11
R 3sAZ 40* 2* 126& 7 143l 9 79& 6
s
88k 7*
33• 3 36& 3* 126+ 11 143* 10 S2+ 8 67& 6“
*p< 0,05,ANOVAofthedilferencas(treatedgroupsvs.placebo,)
We conclude that R and S provided comparable prevention of ventricular
dilatation and further decline in systolic dysfunction suggesting aldosterone
contributes to this geometrical remodeling and that antagonism of its receptor
may be equally efficacious to ACE inhibition.
o~grel,aThro~bo~ane~yn*e~$.
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J. Kate,J. Tanouchi,T. Ito, M. Nishino,K. Iwai, H. Tanahashi,Y. Yamada,
T. Kamada.Oaaka Rosai Hospita/, Osaka, Japan
Previous experimental studies have reported that the inhibition of throm-
